Comparison of the epidemiology and co-morbidities of heart failure in the pediatric and adult populations: A retrospective, cross-sectional study

BMC Cardiovascular Disorders

Volumn 6, Issue , 2006, Pages

  Webster, Gregory ^a   Zhang, Jie ^b   Rosenthal, David ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CAUCASIAN; CHILD; COMORBIDITY; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DATA BASE; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; GYNECOLOGIC DISEASE; HEALTH CARE FACILITY; HEART FAILURE; HEMATOLOGIC DISEASE; HOSPITAL CARE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFANT; INFECTION; KIDNEY DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; NEUROLOGIC DISEASE; OBSTETRICS; ORTHOPEDICS; OTORHINOLARYNGOLOGY; PATIENT CARE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; SAMPLE SIZE; SEX RATIO; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES;

EID: 33746926386     PISSN: 14712261     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-6-23     Document Type: Article

References (23)

1. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987, 316:1429-1435.
2. The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991, 325:293-302.
3. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, et al.: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991, 325:303-310.
4. The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992, 327:685-691.
5. Packer M, Colucci WS, Sackner-Bernstein JD, Liang CS, Goldscher DA, Freeman I, Kukin ML, Kinhal V, Udelson JE, Klapholz M, Gottlieb SS, Pearle D, Cody RJ, Gregory JJ, Kantrowitz NE, LeJemtel TH, Young ST, Lukas MA, Shusterman NH: Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. Circulation 1996, 94:2793-2799.
6. Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger RE, Kubo SH, Narahara KA, Ingersoll H, Krueger S, Young S, Shusterman N: Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation 1996, 94:2807-2816.
7. Colucci WS, Packer M, Bristow MR, Gilbert EM, Cohn JN, Fowler MB, Krueger SK, Hershberger R, Uretsky BF, Bowers JA, Sackner-Bernstein JD, Young ST, Holcslaw TL, Lukas MA: Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation 1996, 94:2800-2806.
8. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999, 341:709-717.
9. Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, El Allaf D, Vitovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus KL, Janosi A, Thorgeirsson G, Dunselman PH, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P: Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. Jama 2000, 283:1295-1302.
10. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL: Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001, 344:1651-1658.
11. Kenchaiah S, Narula J, Vasan RS: Risk factors for heart failure. Med Clin North Am 2004, 88(5):1145-1172.
12. Schellenbaum GD, Rea TD, Heckbert SR, Smith NL, Lumley T, Roger VL, Kitzman DW, Taylor HA, Levy D, Psaty BM: Survival associated with two sets of diagnostic criteria for congestive heart failure. Am J Epidemiol 2004, 160(7):628-635.
13. Ferencz C, Rubin JD, McCarter RJ, Brenner JI, Neill CA, Perry LW, Hepner SI, Downing JW: Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol 1985, 121(1):31-36.
14. Lipshultz SE, Sleeper LA, Towbin JA, Lowe AA, Orav EJ, Cox GF, Lurie PR, McCoy KL, McDonald MA, Messere JE, Colan SD: The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003, 348:1647-1655.
15. Arola A, Jokinen E, Ruuskanen O, Saraste M, Pesonen E, Kuusela AL, Tikanoja T, Paavilainen T, Simell O: Epidemiology of idiopathic cardiomyopathies in children and adolescents - a nationwide study in Finland. Am J Epidemiol 1997, 146:385-93.
16. Boucek MM, Edwards LB, Keck BM, Trulock EP, Taylor DO, Hertz MI: Registry for the International Society for Heart and Lung Transplantation: seventh official pediatric report - 2004. J Heart Lung Transplant 2004, 23(8):933-947.
17. Chen SC, Nouri S, Balfour I, Jureidini S, Appleton RS: Clinical profile of congestive cardiomyopathy in children. J Am Coll Cardiol 1990, 15(1):189-193.
18. Bilgic A, Ozbarlas N, Ozkutlu S, Ozer S, Ozme S: Cardiomyopathies in children. Clinical, epidemiological and prognostic evaluation. Jpn Heart J 1990, 31(6):789-797.
19. Nugent AW, Daubeney PE, Chondros P, Carlin JB, Cheung M, Wilkinson LC, Davis AM, Kahler SG, Chow CW, Wilkinson JL, Weintraub RG: The epidemiology of childhood cardiomyopathy in Australia: N Engl J Med 2003, 348(17):1639-1646.
20. Manolio TA, Baughman KL, Rodenheffer R, Pearson TA, Bristow JD, Michels VV, Abelmann WH, Harlan WR: Prevalence and etiology of dilated cardiomyopathy. Am J Cardiol 1992, 69:1458-1466.
21. 1997 NIS Technical Documentation. July 2000. Agency for Healthcare Research and Quality, Rockville, MD [http://www.hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp]
22. KID Technical Documentation. December 2001. Agency for Healthcare Research and Quality, Rockville, MD [http://www.hcup-us.ahrq.gov/db/nation/kid/kiddbdocumentation.jsp]
23. Clinical Classifications Software. Fact Sheet. Agency for Healthcare Research and Quality, Rockville, MD [http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccsfactsheet.jsp]